TRAT1 and cancer: Notably, developing TRIM inhibitors for cancer therapy is currently gaining pharmaceutical attention (Zhao et al., 2021), and researchers’ growing interest in TRIM proteins has given an impetus to developing some potential drug designs shown in Table 6.